XAT-13

Overview

XAT-13 is an orally active antiallergic agent. XAT-13 binds to the active pocket of MRGPRX2 , and inhibits C48/80-induced calcium influx and β-hexosaminidase release. XAT-13 can be used for the research of pseudo-allergic diseases.

Application

Products | Products > Disease Areas > Allergy | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Mas-related G-protein-coupled Receptor (MRGPR) | Products > Signaling Pathways > Calcium Channel | Products > Signaling Pathways > Glycosidase

Product Information

• Catalog No.: HY-181891
• CAS No.: 3107904-58-2
• Molecular Formula: C20H16O5
• Molecular Weight: 336.34
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source